Dr. Lubna Kamani is currently an Associate Professor & Director of GI Residency program at the Liaquat National Hospital and is a Consultant at Aga Khan University Hospital. She is also President Pakistan Gastrointestinal and Liver disease Society, and a publication secretory for the Pakistan Society of Gastroenterology (PSG). In addition, she serves as the Co-Chairwomen in the hepatology forum, SAASL. She is a member of the medical women international association (MWIA), Member of the American College of Gastroenterology and Member of Royal College of Physicians (MRCP), Follow American Collège of Gastroenterology (FACG), Follow Royal Collège of Physicians, London, and a Fellow of College of Physicians & Surgeons Pakistan.
Prof. Thomas Schiano is Medical Director of Adult Liver Transplantation and Director of Clinical Hepatology and Intestinal Transplantation at the Recanati/Miller Transplantation Institute.
Dr. Herman is currently the Director of Clinical Research for the Northwell Health Cancer Institute and is also the Chief Medical Officer of a four-year funded grant to create a pancreatic multidisciplinary clinic learning health network across 14 pancreas cancer centers. Recently, he was Professor and Ad Interim Division Head in Radiation Oncology at The University of Texas MD Anderson Cancer Center. Prior to this, he was an Associate Professor at Johns Hopkins University Department of Radiation Oncology, where he initiated and co-directed the Pancreatic Multidisciplinary Clinic. He has been a writing member for the NCCN and ACR guidelines committees and on the medical advisory board and Chief Medical Officer for the Pancreatic Cancer Action Network as well as a member of the NIH Neuroendocrine and Pancreas Task Forces. He is the author of over 250 peer-reviewed manuscripts and has served as Principal Investigator for several institutional gastrointestinal protocols and is a Co-Investigator (radiation oncology lead) for the Alliance 021101 borderline resectable cancer trial. His major areas of clinical and basic research involve identification of novel biomarkers and integration of SBRT and hypofractionated radiation with immunotherapy and targeted therapies.
Jayanta Roy-Chowdhury graduated from Medical College, Calcutta, India in 1965. He received clinical training at the Mount Sinai Hospital Services, New York and the State University of New York at Stony Brook. He was also trained in Edinburgh, UK, where he received his Membership of the Royal College of Physicians (MRCP, UK). Dr. Roy Chowdhury is Board certified in Internal Medicine and Gastroenterology and Hepatology. He joined the faculty of Medicine at the Albert Einstein College of Medicine, New York in 1975. Currently, he is a Professor in the Departments of Medicine and Molecular Genetics. He directs the Gene Therapy Core of the Institute of Human genetics, Albert Einstein College of Medicine. Since 1985, Dr. Roy-Chowdhury has focused on liver cell transplantation and liver-directed gene therapy. His contributions include discovery of the molecular basis of Crigler-Najjar syndrome, types 1 & 2, and Gilbert syndrome. Dr. Roy-Chowdhury and his collaborators performed the first long-term liver-directed gene therapy for a metabolic disease in LDL receptor-deficient rabbits and the first successful hepatocyte transplantation for the treatment of Crigler-Najjar syndrome. Dr. Roy Chowdhury has been a member of NIH Study Sections for many years and had Chaired the National Research Grant Committee of the American Liver Foundation for five years. He has been, on the editorial board of several journals. Dr. Roy-Chowdhury has authored over three hundred publications, including 80 book chapters and sections of an encyclopedia.
Dr. Sanjaya Satapathy graduated from Veer Surendra Sai Medical College of Sambalpur University, India. He completed his Residency in Internal Medicine training at the same college, and then 2 years of Hepatology training at the Post Graduate Institute of Medical Education and Research at Chandigarh, India.
He then moved to New Delhi where he joined G.B.Pant Hospital as a Gastroenterology Fellow under the mentorship Professor ShivSarin. After completion of his training, he moved to the United States in 2004. He re-trained in Internal Medicine (New York Medical College), Gastroenterology(North Shore LIJ Hospital, New York), and went on to complete a Transplant Hepatology Fellowship at the Mount Sinai Medical Center at New York. Dr. Satapathy is board-certified in Internal Medicine, Gastroenterology, and Transplant Hepatology by the American Board of Internal Medicine. He has also earned a Masters in Epidemiology and Clinical Investigation from the University of Tennessee Health Sciences Center.
He is currently a Professor of Medicine at the Donald and Barbara Zucker School of Medicine at the Hofstra University, and serving as the Medical Director of Liver Transplantation at the Northshore University Hospital/Northwell Health. Prior to joining Northwell Health, he was Transplant Hepatologist at the Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, and served as a Tenured Associate Professor until 2018. He is also a skilled advanced therapeutic endoscopist, particularly in ERCP and EUS. Dr. Satapathy’s research focuses on post-transplant outcomes, particularly in patients with NASH, and hepatitis C. He has published more than100 peer-reviewed publications.
Dr. Satapathy has received several accolades throughout his career and currently a Fellow of American Society of Gastrointestinal Endoscopy (FASGE), American College of Gastroenterology(FACG), American Gastroenterological Association (AGAF), American Association of the Liver Diseases (FAASLD). Dr. Satapathy is serving as an Academic Editor of the journal Medicine, and Editor-in-Chief for Translational Gastroenterology & Hepatology, and reviewer of several international peer-reviewed journals including Hepatology, Gastroenterology, Transplantation and LiverTransplantation to name a few. He has served as Member National Affairs Committee and the International Affairs Committee of the American College of Gastroenterology. He is also spearheading an international collaboration group that aims to study a non-alcoholic fatty liver disease that is now considered a global public health crisis and slated to be the lead indication for liver transplantation in the next decade.